Product Code: ETC6189169 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Australia Preimplantation Genetic Testing Market is on the rise due to the increasing adoption of genetic testing during IVF procedures. Preimplantation genetic testing (PGT) is a process used to identify genetic abnormalities in embryos before implantation, helping to prevent inherited diseases and improve the chances of a successful pregnancy. With the growing awareness of genetic disorders and the desire for healthier pregnancies, more couples are turning to PGT as part of their family planning process. Advances in genetic technology and the increasing availability of genetic counseling services are contributing to the growth of this market. As assisted reproductive technologies continue to evolve, the preimplantation genetic testing market in Australia is expected to grow in line with demand for personalized and precision healthcare.
The Australia Preimplantation Genetic Testing Market is evolving rapidly, with genetic testing becoming a standard procedure for couples undergoing IVF. This market benefits from the increasing desire for healthier pregnancies and the growing adoption of IVF and other assisted reproductive technologies. Preimplantation genetic testing (PGT) allows clinicians to detect genetic conditions and select embryos with the least risk of passing on inherited disorders, making it a critical tool in fertility treatments. Additionally, greater awareness about genetic disorders and the availability of advanced genetic screening techniques are pushing the market`s growth.
The Australia preimplantation genetic screening (PGS) technology market faces challenges in terms of technological limitations, high costs, and public perception. While PGS offers significant benefits by identifying chromosomal abnormalities in embryos during IVF, the technology is not without limitations, particularly in terms of the accuracy of screening for certain genetic disorders. The cost of PGS procedures can be prohibitive for many patients, especially when multiple IVF cycles are required, leading to concerns over the affordability of the technology. Public perception of PGS is also a challenge, as ethical questions arise about selecting embryos based on genetic information, particularly when it comes to screening for non-medical traits. The cost-effectiveness and clinical value of PGS remain debated within the medical community, adding to uncertainty in the market. Furthermore, the regulatory landscape surrounding PGS is complex and can vary, creating a challenging environment for companies operating in this space.
The preimplantation genetic testing (PGT) market in Australia is driven by advancements in genetic testing that help couples make informed decisions about the health of their embryos. PGT can identify genetic disorders and chromosomal abnormalities, allowing for healthier pregnancies. Investment opportunities in this market include improving the speed and accuracy of genetic tests, making them more accessible and affordable, and enhancing the integration of PGT with fertility clinics. As the demand for precision medicine and personalized healthcare increases, the PGT market offers significant growth opportunities.
PGT, encompassing both PGD and PGS, is regulated as part of the broader ART and genetic testing policy landscape. The government mandates that all labs offering PGT be accredited and operate under strict quality assurance programs. There are specific guidelines for embryo biopsy, genetic analysis, and patient counseling, coordinated under NHMRC and TGA oversight. Policies are being updated to address newer techniques like next-generation sequencing (NGS) in PGT workflows. Although PGT is largely funded privately, public consultation is ongoing regarding its accessibility and fairness in reproductive care. Ethical review boards evaluate emerging applications to ensure compliance with national genetic ethics frameworks. The government thus ensures scientific rigor, ethical integrity, and patient rights in this fast-developing field.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Preimplantation Genetic Testing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Preimplantation Genetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Preimplantation Genetic Testing Market - Industry Life Cycle |
3.4 Australia Preimplantation Genetic Testing Market - Porter's Five Forces |
3.5 Australia Preimplantation Genetic Testing Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.6 Australia Preimplantation Genetic Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Australia Preimplantation Genetic Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Australia Preimplantation Genetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Australia Preimplantation Genetic Testing Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Australia Preimplantation Genetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Preimplantation Genetic Testing Market Trends |
6 Australia Preimplantation Genetic Testing Market, By Types |
6.1 Australia Preimplantation Genetic Testing Market, By Procedure |
6.1.1 Overview and Analysis |
6.1.2 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Procedure, 2021- 2031F |
6.1.3 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Preimplantation Genetic Screening, 2021- 2031F |
6.1.4 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Preimplantation Genetic Diagnosis, 2021- 2031F |
6.2 Australia Preimplantation Genetic Testing Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Reagents and Consumables, 2021- 2031F |
6.2.3 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.4 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Software, 2021- 2031F |
6.3 Australia Preimplantation Genetic Testing Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Next Generation Sequencing (NGS), 2021- 2031F |
6.3.3 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.3.4 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Fluorescent In-Situ Hybridization (FISH), 2021- 2031F |
6.3.5 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Preimplantation Genetic Testing Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Chromosomal Abnormalities, 2021- 2031F |
6.4.3 Australia Preimplantation Genetic Testing Market Revenues & Volume, By X-linked Diseases, 2021- 2031F |
6.4.4 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Embryo Testing, 2021- 2031F |
6.4.5 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Aneuploidy Screening, 2021- 2031F |
6.4.6 Australia Preimplantation Genetic Testing Market Revenues & Volume, By HLA Typing, 2021- 2031F |
6.4.7 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Preimplantation Genetic Testing Market, By End-Use |
6.5.1 Overview and Analysis |
6.5.2 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Fertility Centers, 2021- 2031F |
6.5.3 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.5.5 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Research Centers, 2021- 2031F |
6.5.6 Australia Preimplantation Genetic Testing Market Revenues & Volume, By Academic Labs, 2021- 2031F |
7 Australia Preimplantation Genetic Testing Market Import-Export Trade Statistics |
7.1 Australia Preimplantation Genetic Testing Market Export to Major Countries |
7.2 Australia Preimplantation Genetic Testing Market Imports from Major Countries |
8 Australia Preimplantation Genetic Testing Market Key Performance Indicators |
9 Australia Preimplantation Genetic Testing Market - Opportunity Assessment |
9.1 Australia Preimplantation Genetic Testing Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.2 Australia Preimplantation Genetic Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Australia Preimplantation Genetic Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Australia Preimplantation Genetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Australia Preimplantation Genetic Testing Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Australia Preimplantation Genetic Testing Market - Competitive Landscape |
10.1 Australia Preimplantation Genetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Australia Preimplantation Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |